Calciphylaxis is a rare disease where calcium gathers in small blood vessels of the fat and skin tissues. It causes blood clots, painful skin ulcers and even serious infections that may lead to death. The disease is mainly observed in patients with kidney failure and are on dialysis or have had a kidney transplant. Calciphylaxis can also been seen in patients without kidney diseases.
Global calciphylaxis treatment market is accounted for a market value of USD xx billion in 2017, and is expected to grow at a CAGR of xx% to reach USD XX billion by 2025.
Global Calciphylaxis Treatment Market value, 2016 to 2025 (in USD billion)
Year Market Value
Global Calciphylaxis Treatment Market Dynamics:
The growth in the industry is mainly due to increasing number of ESRD prevalence globally. Globally, about 4% of ESRD patients are suffering from calciphylaxis every year. Increasing number of ongoing treatment developments that are in pipeline will strengthen the market growth in the forecast period. In November 2017, Sanifit has completed Phase II trial of SNF472 for wound healing in uremic calciphylaxis patients.
Lack of proper availability of treatment and high cost of existing treatments is the key restraint that hampering the market growth.
Global Calciphylaxis Treatment Market - Segment Analysis:
Currently, there is no effective treatment for calciphylaxis and its occurrence is associated with hyperthyroidism. However most of the treatments in calciphylaxis is focused on wound treatment and managing calcium content in the blood.
Global calciphylaxis treatment market is segmented by treatment type and by end-user. By treatment type market is further segmented as drug therapies, hyperbaric oxygen therapy and others. Hyperbaric oxygen therapy is the most prominent treatment, as it helps to increase oxygen delivery to the affected parts of the body and can cure the ulcer in the body. By end-user the market is further segmented in to hospitals and clinics, ambulatory centers and others. Hospitals and clinics accounted for the major share with increasing number of in-patients and rising dialysis patients globally. According to NIH, over 661,000 Americans have kidney failure of which 468,000 individuals are undergoing dialysis treatment.
Global Calciphylaxis Treatment Market - Geography Analysis:
Based of geography the market is segmented in to North America, South America, Europe, Asia Pacific and Rest of world. North America is accounted for the major share in the global calciphylaxis treatment market with increasing ageing population and rising prevalence chronic kidney diseases in the region. The growth in the region is mainly contributed by the US. According to American Kidney Fund, around 31 million US people have chronic kidney disease (CKD). The prevalence of ESRD has been doubled between 1990 and 2015 in the US. The prevalence of kidney transplant in the US is around 618 per million population.
Global Automotive 3D printing market share, By region, 2017
North America 35%
South America 3%
Asia Pacific 25%
Rest of the world 7%
Global Calciphylaxis Treatment Market - Competitive landscape:
Key players in global calciphylaxis treatment market are Amgen Inc., Smith & Nephew plc, Medtronics, 3M, BSN Medical, ConvaTec Inc., Sanifit, and Hope Pharmaceuticals. Key players in the industry are investing in R&D and developing new therapies to be competitive in the market globally. For instance, in June 2018, Hope Pharmaceuticals has started enrollment of candidates for Phase III study of Sodium Thiosulfate on calciphylaxis-related pain in Canada and the US at CALISTA center.
Why Purchase the Report?
● Visualize the composition of the Global Calciphylaxis Treatment across each indication, in terms of type and treatment options, highlighting the key commercial assets and players.
● Identify commercial opportunities in Global Calciphylaxis Treatment market by analyzing trends and co-development deals.
● Excel data sheet with thousands of data points of the Global Calciphylaxis Treatment market.
● PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
● Product mapping in excel for the key products of all major market players
● Equipment Suppliers/ Buyers
● Service Providers/ Buyers
● Industry Investors/Investment Bankers
● Education & Research Institutes
● Research Professionals
● Emerging Companies
1. Global Calciphylaxis Treatment market - Scope and Methodology
1.1. Research Methodology
1.2. Scope of the market
2. Global Calciphylaxis Treatment market – Trends and Developments
2.1. Key Market trends and Developments
3. Global Calciphylaxis Treatment Market - Industry Analysis
3.3. Porter’s Five Forces Analysis
4. Global Calciphylaxis Treatment market - Segment Analysis
4.1. By Treatment Type
4.1.1. Drug Therapy
4.1.2. Hyperbaric Oxygen Therapy
4.1.3. Others (including Tissue plasminogen activator (TPA), Wound Treatment)
4.2. By End-User
4.2.1. Hospital and Clinics
4.2.2. Ambulatory Centers
5. Global Calciphylaxis Treatment market - Geography Analysis
5.1. North America
5.2.4. Rest of Europe
5.3. South America
5.3.3. Rest of South America
5.4. Asia Pacific
5.4.4. Rest of Asia Pacific
5.5. Rest of the World
6. Competitive Landscape
6.1. Market Share/ Rank Analysis
6.2. Key strategies adopted by market players
7. Company Profiles
7.1. Amgen Inc.
7.2. Smith & Nephew plc
7.5. BSN Medical
7.6. ConvaTec Inc.
7.8. Hope Pharmaceuticals
8.2. Contact Us